2014
DOI: 10.1097/01.mib.0000436277.13917.c4
|View full text |Cite
|
Sign up to set email alerts
|

Initial Disease Course and Treatment in an Inflammatory Bowel Disease Inception Cohort in Europe

Abstract: In this cohort, immunological therapy was initiated within the first months of disease. Surgery and hospitalization rates did not differ between patients from eastern and western Europe, although more western European patients received biological agents and were comparable to previous population-based inception cohorts.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

9
59
2
3

Year Published

2014
2014
2019
2019

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 76 publications
(73 citation statements)
references
References 41 publications
9
59
2
3
Order By: Relevance
“…Furthermore, hospitalization rates decreased after the first year of the diagnosis. Finally, even lower early hospitalization rates were reported in the very recent, populationbased EpiCom study in patients diagnosed in 2010 [21] . Cumulative CD-related hospitalization rates were 20% and 16% in western and eastern European centers, with 42% and 35% of events related to surgery, respectively.…”
Section: Discussionmentioning
confidence: 74%
“…Furthermore, hospitalization rates decreased after the first year of the diagnosis. Finally, even lower early hospitalization rates were reported in the very recent, populationbased EpiCom study in patients diagnosed in 2010 [21] . Cumulative CD-related hospitalization rates were 20% and 16% in western and eastern European centers, with 42% and 35% of events related to surgery, respectively.…”
Section: Discussionmentioning
confidence: 74%
“…Two recent population-based cohorts demonstrated a significant reduction in surgery rates in CD over time to be associated with increased and earlier use of thiopurines,16 21 while a beneficial effect on the early disease course could not be demonstrated in two randomised, controlled trials 29 30. In the present cohort, treatment with immunomodulators, as well as biologicals, was initiated early in the disease course 31. Immunomodulators were found to significantly reduce the risk of surgery and hospitalisation while it non-significantly reduced the risk of progression.…”
Section: Discussionmentioning
confidence: 85%
“…[15] A similar operation frequency of 7.6% after five years was reported from a Canadian study of patients diagnosed between the years 1984 and 2008. [16] Although only providing 1-year data, the ECCO-Epicom studies reporting the outcome of patients diagnosed 2010 and 2011 [17,18] demonstrate an operation frequency of 3% and 0.4%, respectively.…”
Section: Scandinavian Journal Of Gastroenterologymentioning
confidence: 99%